Efficacy of gene therapy for X-linked severe combined immunodeficiency.
暂无分享,去创建一个
Frederic D. Bushman | Lily E. Leiva | Capucine Picard | Salima Hacein-Bey-Abina | F. Bushman | F. Rieux-Laucat | A. Fischer | J. Casanova | C. Berry | C. Picard | A. Durandy | M. Cavazzana‐Calvo | Gary P. Wang | S. Latour | A. Lim | J. Hauer | S. Blanche | S. Hacein-Bey-Abina | R. Sorensen | B. Belohradsky | L. Leiva | Alain Fischer | Jean-Laurent Casanova | Ricardo U. Sorensen | Marina Cavazzana-Calvo | Anne Durandy | Annick Lim | Stéphane Blanche | C. Martinache | M. Debré | Marianne Debré | Charles C. Berry | Sylvain Latour | Bernd H. Belohradsky | Frédéric Rieux-Laucat | Julia Hauer | Chantal Martinache
[1] A. Fischer,et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. , 2002, The New England journal of medicine.
[2] Sami Al-Hajjar,et al. B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans , 2010, The Journal of experimental medicine.
[3] Christine Kinnon,et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.
[4] W. Leonard,et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993. , 2008, Journal of immunology.
[5] F. Bushman,et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.
[6] J. V. van Dongen,et al. Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential. , 2006, Blood.
[7] C. Baum. Insertional mutagenesis in gene therapy and stem cell biology , 2007, Current opinion in hematology.
[8] J. Tanner,et al. 1 Normal growth and techniques of growth assessment , 1986 .
[9] J. Roberts,et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 1999, The New England journal of medicine.
[10] F. Deist,et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. , 2000, Science.
[11] A. Fischer,et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. , 2009, Blood.
[12] Christine Kinnon,et al. Mutations in TNFRSF13B Encoding TACI Are Associated With Common Variable Immunodeficiency in Humans , 2006, Pediatrics.
[13] A. Fischer,et al. Treatment of an infant with X-linked severe combined immunodeficiency ( SCID-X 1 ) by gene therapy in Australia , 2000 .
[14] R. de Waal Malefyt,et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] Alessandro Aiuti,et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. , 2009, The New England journal of medicine.
[16] W. Leonard. Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.
[17] J. Banchereau,et al. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3 , 1994, The Journal of experimental medicine.
[18] G. Sempowski,et al. Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras. , 2009, Blood.
[19] A. Fischer,et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. , 2007, Blood.
[20] Frederic D. Bushman,et al. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. , 2010, Blood.
[21] N. Tanaka,et al. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. , 1996, Annual review of immunology.
[22] A. Fischer,et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 , 2003, The Lancet.